Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 [Photodynamic therapy-trends and new developments].

Literature DB >> 33301063

[Photodynamic therapy-trends and new developments].

Abstract

Photodynamic therapy (PDT) is a licensed and established procedure for the treatment of actinic keratosis, basal cell carcinoma, and Bowen's disease, but there are several new and clinically relevant developments and trends. These concern on the one hand the main components of PDT, which are the photosensitizer and the light source. Furthermore, modifications and therapy combinations have been developed that lead to an improved therapeutic efficacy. An important aspect of field-directed PDT is also skin cancer prevention. Finally, PDT has been used successfully for nonlicensed indications including inflammatory diseases and skin rejuvenation. This article focuses on these new developments and on recent guideline recommendations.

Entities: Disease

Keywords: 5‑aminolevulinic acid; Actinic keratosis; Methyl-5-amino-4-oxopentanoate; Photorejuvenation; Skin cancer

Mesh：

Substances：

Year: 2020 PMID： 33301063 DOI： 10.1007/s00105-020-04737-6

Source DB: PubMed Journal: Hautarzt ISSN： 0017-8470 Impact factor: 0.751

30 in total

Review 1. Aesthetic effects of topical photodynamic therapy.

Authors: E Kohl; L A R Torezan; M Landthaler; R-M Szeimies
Journal: J Eur Acad Dermatol Venereol Date: 2010-11 Impact factor: 6.166

2. Lesion intensified field therapy (LIFT): A new concept in the treatment of actinic field cancerization.

Authors: S A Braun; P A Gerber
Journal: J Eur Acad Dermatol Venereol Date: 2016-10-25 Impact factor: 6.166

3. S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma - short version, part 1: diagnosis, interventions for actinic keratoses, care structures and quality-of-care indicators.

Authors: Markus V Heppt; Ulrike Leiter; Theresa Steeb; Teresa Amaral; Andrea Bauer; Jürgen C Becker; Eckhard Breitbart; Helmut Breuninger; Thomas Diepgen; Thomas Dirschka; Thomas Eigentler; Michael Flaig; Markus Follmann; Klaus Fritz; Rüdiger Greinert; Ralf Gutzmer; Uwe Hillen; Stephan Ihrler; Swen Malte John; Oliver Kölbl; Klaus Kraywinkel; Christoph Löser; Dorothée Nashan; Seema Noor; Monika Nothacker; Christina Pfannenberg; Carmen Salavastru; Lutz Schmitz; Eggert Stockfleth; Rolf-Markus Szeimies; Claas Ulrich; Julia Welzel; Kai Wermker; Carola Berking; Claus Garbe
Journal: J Dtsch Dermatol Ges Date: 2020-03 Impact factor: 5.584

Review 4. Translational medicine in the field of ablative fractional laser (AFXL)-assisted drug delivery: A critical review from basics to current clinical status.

Authors: Merete Haedersdal; Andrés M Erlendsson; Uwe Paasch; R Rox Anderson
Journal: J Am Acad Dermatol Date: 2016-02-28 Impact factor: 11.527

5. Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator-blinded, controlled, phase III study throughout Europe.

Authors: J-P Lacour; C Ulrich; Y Gilaberte; V Von Felbert; N Basset-Seguin; B Dreno; C Girard; P Redondo; C Serra-Guillen; I Synnerstad; M Tarstedt; A Tsianakas; A W Venema; N Kelleners-Smeets; H Adamski; B Perez-Garcia; M J Gerritsen; S Leclerc; N Kerrouche; R-M Szeimies
Journal: J Eur Acad Dermatol Venereol Date: 2015-10-05 Impact factor: 6.166

6. Methyl aminolevulinate daylight photodynamic therapy applied at home for non-hyperkeratotic actinic keratosis of the face or scalp: an open, interventional study conducted in Germany.

Authors: S Karrer; R A G Aschoff; R Dominicus; G Krähn-Senftleben; G G Gauglitz; A Zarzour; N Kerrouche; R Chavda; R-M Szeimies
Journal: J Eur Acad Dermatol Venereol Date: 2019-02-22 Impact factor: 6.166

7. Fractional CO(2) laser-assisted drug delivery.

Authors: Merete Haedersdal; Fernanda H Sakamoto; William A Farinelli; Apostolos G Doukas; Josh Tam; R Rox Anderson
Journal: Lasers Surg Med Date: 2010-02 Impact factor: 4.025

8. Penetration enhancement of two topical 5-aminolaevulinic acid formulations for photodynamic therapy by erbium:YAG laser ablation of the stratum corneum: continuous versus fractional ablation.

Authors: Bernadette Forster; Annette Klein; Rolf-Markus Szeimies; Tim Maisch
Journal: Exp Dermatol Date: 2010-07-16 Impact factor: 3.960

9. Fractional 1,927 nm Thulium Laser Plus Photodynamic Therapy Compared and Combined for Photodamaged Décolleté Skin: A Side-by-Side Randomized Controlled Trial.

Authors: Kristoffer Hendel; Mette Mogensen; Emily Wenande; Christine Dierickx; Merete Haedersdal; Katrine Togsverd-Bo
Journal: Lasers Surg Med Date: 2019-12-01 Impact factor: 4.025

10. Efficacy and safety of conventional versus daylight photodynamic therapy in children affected by multiple facial flat warts.

Authors: Francesco Borgia; Roberta Giuffrida; Marialorena Coppola; Rosaria Princiotta; Mario Vaccaro; Fabrizio Guarneri; Serafinella Patrizia Cannavò
Journal: Photodiagnosis Photodyn Ther Date: 2020-05-25 Impact factor: 3.631

1 in total

Review 1. The photosensitizer-based therapies enhance the repairing of skin wounds.

Authors: Xiaoying Ning; Gang He; Weihui Zeng; Yumin Xia
Journal: Front Med (Lausanne) Date: 2022-08-11

1 in total